Cargando…

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis

INTRODUCTION: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The pathophysiology of MS is complex and is said to be influenced by multiple environmental determinants, including diet. We and others have previously demonstrated how consumption of bovine...

Descripción completa

Detalles Bibliográficos
Autores principales: Chunder, Rittika, Heider, Thorsten, Kuerten, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364054/
https://www.ncbi.nlm.nih.gov/pubmed/37492579
http://dx.doi.org/10.3389/fimmu.2023.1202006
_version_ 1785076771230580736
author Chunder, Rittika
Heider, Thorsten
Kuerten, Stefanie
author_facet Chunder, Rittika
Heider, Thorsten
Kuerten, Stefanie
author_sort Chunder, Rittika
collection PubMed
description INTRODUCTION: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The pathophysiology of MS is complex and is said to be influenced by multiple environmental determinants, including diet. We and others have previously demonstrated how consumption of bovine milk can aggravate disease severity in MS patients, which can be explained by molecular mimicry between milk antigens and those expressed within the CNS. In this study we set out to identify alternatives to drinking cow milk which might be less detrimental to MS patients who have a genetic predisposition towards developing antibody titers against bovine milk antigens that cross-react with CNS antigens. METHODS: To this end, we screened 35 patients with MS and 20 healthy controls for their IgG reactivity against an array of animal-sourced milk, plant-based alternatives as well as individual antigens from bovine milk. RESULTS: We demonstrate that MS patients have a significantly higher IgG response to animal-sourced milk, especially cow milk, in comparison to healthy donors. We also show that the reactivity to cow milk in MS patients can be attributed to reactivity against different bovine milk antigens. Finally, our correlation data indicate the co-existence of antibodies to individual bovine milk antigens and their corresponding cross-reactive CNS antigens. DISCUSSION: Taken together, we suggest screening of blood from MS patients for antibodies against different types of milk and milk antigens in order to establish a personalized diet regimen.
format Online
Article
Text
id pubmed-10364054
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103640542023-07-25 The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis Chunder, Rittika Heider, Thorsten Kuerten, Stefanie Front Immunol Immunology INTRODUCTION: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The pathophysiology of MS is complex and is said to be influenced by multiple environmental determinants, including diet. We and others have previously demonstrated how consumption of bovine milk can aggravate disease severity in MS patients, which can be explained by molecular mimicry between milk antigens and those expressed within the CNS. In this study we set out to identify alternatives to drinking cow milk which might be less detrimental to MS patients who have a genetic predisposition towards developing antibody titers against bovine milk antigens that cross-react with CNS antigens. METHODS: To this end, we screened 35 patients with MS and 20 healthy controls for their IgG reactivity against an array of animal-sourced milk, plant-based alternatives as well as individual antigens from bovine milk. RESULTS: We demonstrate that MS patients have a significantly higher IgG response to animal-sourced milk, especially cow milk, in comparison to healthy donors. We also show that the reactivity to cow milk in MS patients can be attributed to reactivity against different bovine milk antigens. Finally, our correlation data indicate the co-existence of antibodies to individual bovine milk antigens and their corresponding cross-reactive CNS antigens. DISCUSSION: Taken together, we suggest screening of blood from MS patients for antibodies against different types of milk and milk antigens in order to establish a personalized diet regimen. Frontiers Media S.A. 2023-07-10 /pmc/articles/PMC10364054/ /pubmed/37492579 http://dx.doi.org/10.3389/fimmu.2023.1202006 Text en Copyright © 2023 Chunder, Heider and Kuerten https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Chunder, Rittika
Heider, Thorsten
Kuerten, Stefanie
The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title_full The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title_fullStr The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title_full_unstemmed The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title_short The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
title_sort prevalence of igg antibodies against milk and milk antigens in patients with multiple sclerosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364054/
https://www.ncbi.nlm.nih.gov/pubmed/37492579
http://dx.doi.org/10.3389/fimmu.2023.1202006
work_keys_str_mv AT chunderrittika theprevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis
AT heiderthorsten theprevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis
AT kuertenstefanie theprevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis
AT chunderrittika prevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis
AT heiderthorsten prevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis
AT kuertenstefanie prevalenceofiggantibodiesagainstmilkandmilkantigensinpatientswithmultiplesclerosis